Key result
Laparoscopic sleeve gastrectomy in morbidly obese patients aged ≥60 years resulted in a mean excess weight loss of 66.1% and a mean BMI of 34.4 at 3 years, with no mortality.
Why the study?
Morbid overweight in elderly patients is a growing health issue, but the advantages and results of laparoscopic sleeve gastrectomy in patients over 60 years old have received minimal attention.
Does laparoscopic sleeve gastrectomy improve weight loss and comorbidities in elderly obese patients?
Observational (n=12)
No
Does laparoscopic sleeve gastrectomy improve weight loss and comorbidities in elderly obese patients?
Laparoscopic sleeve gastrectomy is effective for weight loss and comorbidity resolution in elderly obese patients, though larger studies are needed to assess safety.
Answers are grounded in this paper and cite their sources.
Supports feasibility of sleeve gastrectomy in obese patients ≥60 years; leaves open confirmation of safety and efficacy in larger trials.
BACKGROUND: Laparoscopic sleeve gastrectomy (LSG) represents the most performed bariatric surgical procedure worldwide. Morbid Overweight in elderly patients is becoming a significant health problem even in Italy. As well as in younger age groups, bariatric surgery could be indicated even in this subset of patients. However the advantages and results of LSG in patients over 60 years old have received minimal attention. METHODS: The records of 375 patients underwent LSG between 2008 and 2016 were reviewed. In the entire series 18 patients were aged 60 years or older at the time of surgery. Since a 3 years follow-up was available for 12 patients out of the 18 aged over 60 we included in the study only these. General epidemiologic data, clinical findings, BMI and comorbidities surgical treatment and follow-up data were collected; postoperative measurements such as operative time, intraoperative complications, mortality rate, length of stay, incidence of early and late complications, Body mass Index (BMI), excess weight loss rate (EWL%) and comorbidities resolution were also recorded. RESULTS: LSG was successfully performed for all geriatric patients. Global complications rate was 16.6% At 3 years mean BMI was 34.4±3.8 with a mean EWL% 66.1±31.9. Postoperative resolution of obesity comorbidities was observed; Hypertension (71.4%), type 2 Diabetes Mellitus (T2DM) (50.0%), obstructive sleep apnea syndrome (OSAS) (66.6%) respectively. No intraoperative complications or mortality were recorded. CONCLUSIONS: LSG offered cure in geriatric patients affected by morbid obesity for weight loss and comorbidities resolution. Larger studies are necessary to analyze and minimize the incidence of postoperative complications associated to this surgical procedure in elderly patients.
No takes yet. Share an insight, caveat, or question.
Bianco et al. (2020) conducted an observational in Morbid obesity (n=12). Laparoscopic sleeve gastrectomy was evaluated on Mean excess weight loss (EWL%) at 3 years. Laparoscopic sleeve gastrectomy in morbidly obese patients aged ≥60 years resulted in a mean excess weight loss of 66.1% and a mean BMI of 34.4 at 3 years, with no mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: